{"slideshow_credits": null, "snippet": "The claims in Allergan\u2019s lawsuit against Valeant and William Ackman are of the ho-hum type that targets often raise to fend off \u2013 or at least slow down \u2013 a bidder, write Peter J. Henning and Steven Davidoff Solomon.", "abstract": "The claims in Allergan\u2019s lawsuit against Valeant and William Ackman are of the ho-hum type that targets often raise to fend off \u2013 or at least slow down \u2013 a bidder, write Peter J. Henning and Steven Davidoff Solomon.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"lastname": "HENNING", "rank": 1, "firstname": "Peter", "role": "reported", "organization": "", "middlename": "J."}, {"lastname": "SOLOMON", "rank": 2, "firstname": "Steven", "role": "reported", "organization": "", "middlename": "Davidoff"}], "original": "By PETER J. HENNING and STEVEN DAVIDOFF SOLOMON"}, "web_url": "http://dealbook.nytimes.com/2014/08/01/allerganstakeover-defense-speed-bump/", "lead_paragraph": null, "headline": {"main": "Botox Maker Allergan's Takeover Defense Speed Bump", "kicker": "DealBook"}, "_id": "53dbef9438f0d8555c69badf", "word_count": "1144", "multimedia": [{"height": 126, "url": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-articleLarge.jpg", "legacy": {"xlarge": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-thumbStandard.jpg", "legacy": {"thumbnail": "images/2014/08/02/business/dbpix-allergan-henning/dbpix-allergan-henning-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-08-01T15:50:02Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "persons", "value": "Khuzami, Robert S", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "2"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Suits and Litigation (Civil)", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Insider Trading", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}